James Walker: Unscripted

A free online calculator for an experimental drug seems trivial. But it reveals the hidden operational layer where scientific breakthroughs are forged.

Zoomcar's latest earnings are a masterclass in strategic pivots. By prioritizing high-value trips over volume, the Indian car-sharing giant is finding profit.

Infios's dual leadership in IDC MarketScape reports for B2B and B2C signals a new era where unified, AI-driven execution is no longer optional.

As U.S. alcohol sales dip, Prosecco thrives. Gemma di Luna's brand refresh and new single-serve pack reveal a sharp strategy to win the modern consumer.

With promising drills at Berrigan Deep and a barrage of advanced surveys, TomaGold is betting big on a data-driven strategy to unlock Chibougamau's riches.

Beyond a vibrant tribute to Kashmir's culture, Asian Paints' new art initiatives are a masterclass in brand strategy amid rising competition. Here's the real story.

Aardvark Therapeutics faces a pivotal moment as an FDA clinical hold halts its lead drug trial, leaving the Prader-Willi Syndrome community waiting.

Reed's Q2 results show major operational gains and a shrinking net loss, but a steep sales decline and a looming cash crunch raise critical questions.

Radiant Logistics has refinanced its debt, securing a flexible $200M credit line with better terms, extending its financial runway and fueling its M&A ambitions.

Australia's capital is future-proofing its water supply with a massive upgrade, turning to advanced membrane technology to tackle population growth.

A new partnership between Carelon Research and Manifold promises to unlock life sciences insights by letting researchers analyze sensitive health data without moving it.

With a 23% revenue jump and losses halved, 908 Devices is proving its handheld chemical detectors are more than just gadgets—they're a strategic necessity.

With the appointment of Dr. Jeffrey Sherman, Kalohexis signals a major push to conquer the challenging metabolic disease market with its novel pipeline.

Wayfinder's nomination for a top DoD award reveals a powerful lesson: A culture of service is a strategic asset, even in the most unexpected industries.

Amid tenant shifts and market headwinds, EfTEN Real Estate Fund's July NAV growth reveals a story of strategic agility and financial acumen in a complex market.

A new survey from Ollie's reveals a stark reality: 88% of shoppers now see bargain hunting as essential, cementing the dominance of off-price retail.

Array Digital posts huge Q2 profits from asset sales and tower growth, but a takeover offer from majority owner TDS and the DISH bankruptcy loom large.

Zentalis Pharmaceuticals is pursuing a dual strategy for its ovarian cancer drug, azenosertib, aiming for fast market entry while securing long-term validation.

Resmed posts record revenue and boosts shareholder returns, but its strategic pivot and operational hurdles reveal a more complex story of medtech leadership.

Sprout Social's stellar Q2 profit beat isn't just a good quarter; it's a strategic overhaul. A look at its high-stakes bet on enterprise clients and AI.